Evidence map›Paper›PMID 33811137›Full record

Observational studyOpen heart2021

Undiagnosed SARS-CoV-2 infection and outcome in patients with acute MI and no COVID-19 symptoms.

Zubair Akhtar, Fahmida Chowdhury, Mohammad Abdul Aleem, Probir Kumar Ghosh, Mahmudur Rahman, Mustafizur Rahman, Mohammad Enayet Hossain, Mariya Kibtiya Sumiya, A K M Monwarul Islam, Mir Jamal Uddin and 3 more

Open access · goldAbstract readComparative StudyObservational Study
In one paragraph

Observational study in Open heart, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. The impact of COVID-19 and COVID vaccination on cardiovascular outcomes.European heart journal supplements : journal of the European Society of Cardiology · 2023
    Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 5 countries.

Zubair AkhtarInfectious Diseases Division, ICDDRB, Dhaka, Dhaka District, Bangladesh zakhtar@icddrb.org.ORCID 0000-0001-5054-9243
Fahmida ChowdhuryInfectious Diseases Division, ICDDRB, Dhaka, Dhaka District, Bangladesh.
Mohammad Abdul AleemInfectious Diseases Division, ICDDRB, Dhaka, Dhaka District, Bangladesh.
Probir Kumar GhoshInfectious Diseases Division, ICDDRB, Dhaka, Dhaka District, Bangladesh.
Mahmudur RahmanInfectious Diseases Division, ICDDRB, Dhaka, Dhaka District, Bangladesh.
Mustafizur RahmanInfectious Diseases Division, ICDDRB, Dhaka, Dhaka District, Bangladesh.
Mohammad Enayet HossainInfectious Diseases Division, ICDDRB, Dhaka, Dhaka District, Bangladesh.
Mariya Kibtiya SumiyaInfectious Diseases Division, ICDDRB, Dhaka, Dhaka District, Bangladesh.
A K M Monwarul IslamDepartment of Cardiology, National Institute of Cardiovascular Diseases Dhaka (NICVD), Dhaka, Bangladesh.
Mir Jamal UddinDepartment of Cardiology, National Institute of Cardiovascular Diseases Dhaka (NICVD), Dhaka, Bangladesh.
C Raina MacIntyreBiosecurity Research Program, Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.
Sara CajanderDepartment of Infectious Diseases, Orebro University, Orebro, Sweden.
Ole FrobertDepartment of Cardiology, Orebro University Hospital, Orebro, Sweden.ORCID 0000-0002-5846-345X
International Centre for Diarrhoeal Disease Research · BDNational Institute of Cardiovascular Diseases · PKÖrebro University · SEÖrebro University Hospital · SEUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe aimed to determine the prevalence and outcome of occult infection with SARS-CoV-2 and influenza in patients presenting with myocardial infarction (MI) without COVID-19 symptoms.

methodsWe conducted an observational study from 28 June to 11 August 2020, enrolling patients admitted to the National Institute of Cardiovascular Disease Hospital, Dhaka, Bangladesh, with ST-segment elevation MI (STEMI) or non-ST-segment elevation MI who did not meet WHO criteria for suspected COVID-19. Samples were collected by nasopharyngeal swab to test for SARS-CoV-2 and influenza virus by real-time reverse transcriptase PCR. We followed up patients at 3 months (13 weeks) postadmission to record adverse cardiovascular outcomes: all-cause death, new MI, heart failure and new percutaneous coronary intervention or stent thrombosis. Survival analysis was performed using the Kaplan-Meier method.

resultsWe enrolled 280 patients with MI, 79% male, mean age 54.5±11.8 years, 140 of whom were diagnosed with STEMI. We found 36 (13%) to be infected with SARS-CoV-2 and 1 with influenza. There was no significant difference between mortality rate observed among SARS-CoV-2 infected patients compared with non-infected (5 (14%) vs 26 (11%); p=0.564). A numerically shorter median time to a recurrent cardiovascular event was recorded among SARS-CoV-2 infected compared with non-infected patients (21 days, IQR: 8-46 vs 27 days, IQR: 7-44; p=0.378).

conclusionWe found a substantial rate of occult SARS-CoV-2 infection in the studied cohort, suggesting SARS-CoV-2 may precipitate MI. Asymptomatic patients with COVID-19 admitted with MI may contribute to disease transmission and warrants widespread testing of hospital admissions.

Indexed as

Undiagnosed DiseasesAdultAgedBangladeshCOVID-19Disease ProgressionFemaleHospitalizationHumansLongitudinal StudiesMaleMiddle AgedNon-ST Elevated Myocardial InfarctionPredictive Value of TestsPrevalencePrognosisCOVID-19NSTEMISTEMI

Identifiers

PMID33811137
PMCPMC8023755
OpenAlexW3140958619

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.